Alterity Therapeutics (ATHE) Market Capitalization (2015 - 2026)

Alterity Therapeutics (ATHE) Market Capitalization (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Regeneron Pharmaceuticals 63.59 Bn 54.83 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Jun 12, 2026 814,307.08 Bn
Jun 11, 2026 767,934.24 Bn
Jun 10, 2026 762,369.55 Bn
Jun 9, 2026 788,338.31 Bn
Jun 8, 2026 719,706.53 Bn
Jun 5, 2026 723,416.35 Bn
Jun 4, 2026 723,416.35 Bn
Jun 3, 2026 743,820.43 Bn
Jun 2, 2026 745,675.29 Bn
Jun 1, 2026 744,933.29 Bn
May 29, 2026 764,224.41 Bn
May 28, 2026 756,804.77 Bn
May 27, 2026 751,240.07 Bn
May 26, 2026 756,804.77 Bn
May 22, 2026 767,934.24 Bn
May 21, 2026 777,208.84 Bn
May 20, 2026 792,048.14 Bn
May 19, 2026 790,193.27 Bn
May 18, 2026 806,887.43 Bn
May 15, 2026 747,530.25 Bn